Etienne G, Dulucq S, Nicolini F-E, Morisset S, Fort M-P, Schmitt A, Etienne M, Hayette S, Lippert E, Bureau C, Tigaud I, Adiko D, Marit G, Reiffers J, Mahon F-X. Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy. Haematologica 2014; 99(3):458-464; https://doi.org/10.3324/haematol.2013.095158.